advertisement

---

Shalaby WS 9

Showing records 1 to 9 | Display all abstracts from Shalaby WS

109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Massenzio E
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159

---

110006 Persistent Mydriasis following Gonioscopy-Assisted Transluminal Trabeculotomy
Hallaj S; Wong JC
Journal of Glaucoma 2024; 33: 55-58

---

109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Xu D
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159

---

110006 Persistent Mydriasis following Gonioscopy-Assisted Transluminal Trabeculotomy
Wong JC; Shalaby WS
Journal of Glaucoma 2024; 33: 55-58

---

109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Abishek R
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159

---

110006 Persistent Mydriasis following Gonioscopy-Assisted Transluminal Trabeculotomy
Shalaby WS; Shalaby WS; Ayres BD
Journal of Glaucoma 2024; 33: 55-58

---

109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Wibbelsman TD; Sheng Y
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159

---

110006 Persistent Mydriasis following Gonioscopy-Assisted Transluminal Trabeculotomy
Moster MR
Journal of Glaucoma 2024; 33: 55-58

---

109071 RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST
Obeid A; Bhatt S; Zhang Q; Sharpe J; Sharpe J; Park CH; Spirn MJ; Gupta OP; Chiang A; Shukla A; Shalaby WS; Shalaby WS; Shalaby WS; Myers JS; Hsu J
Retina (Philadelphia, Pa.) 2023; 43: 1150-1159

---